← Open Payments lookup

FAHIMA HASAN: Open Payments

NPI 1043933740 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,456 in 82 payments from 18 companies in 2025. Trend: 2023 $630 · 2024 $1,544 · 2025 $1,456

Food & beverage: $1,456
CompanyPaymentsAmount
ABBVIE INC.26$318
Otsuka America Pharmaceutical, Inc.15$285
Biogen, Inc.4$94
Janssen Pharmaceuticals, Inc3$89
Supernus Pharmaceuticals, Inc.2$83
E.R. Squibb & Sons, L.L.C.5$74
Axsome Therapeutics, Inc.4$73
Lundbeck LLC3$60
Gilead Sciences, Inc.3$58
Takeda Pharmaceuticals U.S.A., Inc.3$58

Products named: VRAYLAR, REXULTI, ABILIFY MAINTENA, ZURZUVAE, Qelbree, COBENFY, Auvelity, SPRAVATO.

Industry payments across NE — which companies pay providers there.